Materiale og fremgangsmåder til behandling af udviklingsforstyrrelser indbefattende co-morbid og idiopatisk autisme

摘要

Subjects who were diagnosed with either comorbid or idiopathic autism were treated with acamprosate. Patients generally showed marked improvements in primary outcomes as assessed using, for example, standard clinic measures for functionality including the Clinical Global Impressions Improvement (CGI-I) and the Clinical Global Impressions Severity (CGI-S) scales.